◆ Previously in The Kobe Rule
Episode One established the framework: elite networks operate on a single governing logic — life is graded like livestock. The premium pen looks like merit. It is not. The Kobe Rule predicts that wherever elites manage others as livestock, the same logic operates on the elites themselves — and somewhere in the supply chain, the public is paying for the feed. This episode delivers the receipts.
In May 2026, Palantir Technologies raised its full-year revenue guidance to $7.65–7.66 billion, citing "robust U.S. government demand." In Q1 2026, the company reported U.S. government revenue of 687M, +84% YoY. In 2024, the government segment accounted for 55% of Palantir's total revenue. Its co-founder, Peter Thiel, also co-founded the Dialog network — whose 2026 attendee list included the officials responsible for awarding those contracts.
Palantir is not an anomaly. It is a case study in what this episode calls Taxpayer Wagyu: the systematic transfer of public value — research, infrastructure, risk capital, regulatory protection, tax subsidy — into private prestige, personal wealth, and the ideology of self-made genius.
The premium is real. The independence is not.
"At least half of the total investment required to bring a drug to market comes from the U.S. government. If taxpayers are investing as much as shareholders, the public could expect returns commensurate with those of pharmaceutical companies."
— Fred Ledley, Director, Center for Integration of Science and Industry, Bentley University (2023)The Anatomy of Publicly Funded Private Prestige
Five industries. Five premium brands. Five sets of receipts. Click each sector to read the supply chain.
Palantir's Q1 2026 U.S. government revenue reached $687 million — an 84% year-over-year increase. For 2024, government contracts accounted for 55% of total revenue. The U.S. Army alone has awarded Palantir at least $730 million since 2008; the DoD overall, at least $1.65 billion. A separate $1.3 billion contract with the DoD through 2029 funds Project Maven, an AI targeting system.
The company's founder co-created Dialog, an invitation-only retreat whose 2026 attendee list included direct regulatory and procurement overseers of these same contracts — communicating via personal email to avoid public-records requirements. This is not an accusation of corruption. It is a description of structural access.
The self-made claim: AI visionary disrupting legacy surveillance infrastructure.
The receipt: The U.S. government, by revenue, is Palantir's primary customer. The taxpayer is the feed trough.
A study published in JAMA Health Forum found that the NIH spent $187 billion on basic or applied research related to 354 of the 356 drugs approved by the FDA between 2010 and 2019 — effectively every drug in that decade. NIH spending of approximately $1.4 billion per approved first-in-class drug is comparable to industry's $1.5 billion per drug.
A separate PNAS study found NIH funding contributed to published research associated with every one of the 210 new drugs approved from 2010–2016. Industry then patents, prices, and brands these publicly funded molecules as private innovation.
The self-made claim: Private sector R&D investment creating life-saving innovation.
The receipt: Publicly funded science, privatized at the patent layer. The lab was a government barn. The pill is Wagyu.
In October 2008, the Troubled Asset Relief Program (TARP) was established with a $700 billion authorization, later reduced to $475 billion. $432 billion was ultimately disbursed. Goldman Sachs received $10 billion in TARP funds. Morgan Stanley received $10 billion. Both were described by Treasury Secretary Paulson as "healthy institutions" — while simultaneously receiving emergency backstops unavailable to any non-elite counterparty.
The Federal Reserve's secret emergency loan facility, disclosed only after a Bloomberg FOIA lawsuit, revealed an additional $13 billion in undisclosed income to large banks. The profits from these positions were retained privately. The losses that generated the crisis were absorbed publicly.
The self-made claim: Masters of capital markets, rewarded for sophisticated risk-taking.
The receipt: Losses socialized, gains privatized. The Wagyu premium was backstopped by the taxpayer at the moment of maximum distress.
SpaceX CEO Gwynne Shotwell disclosed in 2025 that the company holds approximately $22 billion in government contracts, with around $15 billion from NASA. In 2024, SpaceX secured at least $3.8 billion in government contracts. According to SpaceX's own IPO filing, one-fifth of 2025 revenue came from government contracts. A June 2026 Space Force award added $6.45 billion ahead of the planned IPO.
The company's founder simultaneously ran the Department of Government Efficiency under President Trump in early 2025, placing him in direct proximity to the officials who oversee federal contracting for his primary commercial sector. The New York Times reported SpaceX was poised to secure billions in new contracts under the resulting administration.
The self-made claim: Bold entrepreneur privatizing space exploration, making government rockets obsolete.
The receipt: NASA and DoD remain the anchor customers. The innovation is partly real. The independence is not.
In December 2022, the Pentagon awarded its Joint Warfighting Cloud Capability (JWCC) contract — with a $9 billion ceiling — to Amazon, Google, Microsoft, and Oracle. The contract provides enterprise-wide cloud services across all DoD security domains through 2028. Its predecessor, JEDI ($10B, 10-year), became one of the most contested procurement battles in U.S. history, with Amazon alleging Trump had improperly redirected the award.
The major cloud providers — the same companies operating the infrastructure through which all digital economic activity now flows — are among the largest government contractors in the United States. The "free market" infrastructure of the digital economy is substantially a publicly contracted, publicly funded service delivered at private margins.
The self-made claim: Private sector innovation creating the infrastructure of the modern economy.
The receipt: The barn is government-contracted. The cloud is a public utility sold as a luxury product.
The Feed Trough at Scale
Documented public value transfers to nominally "private" sectors — selected examples, not exhaustive.
BARS NORMALIZED BY CATEGORY — NOT COMPARATIVE SCALE. TAX BREAK FIGURE ($2.2T) IS A SEPARATE ORDER OF MAGNITUDE.
Why This Is Structural, Not Accidental
The standard defense of these arrangements is: yes, these companies benefit from government contracts and subsidies, but so does everyone — roads, schools, the legal system. This defense is not wrong. It is also not the argument being made here.
The argument is structural: the premium narrative — self-made, free-market, independent genius — is sustained by the same system it claims to be independent of. That is not a coincidence. It is an active, ongoing operation. The narrative is the product, and the product protects the subsidy by making the subsidy invisible.
Consider the tax code. In 2025, the U.S. government lost an estimated 2.2 trillion in revenue through tax expenditures — more than the entire federal deficit that year. Of the three most common deductions, 84% of the benefits went to taxpayers earning over $200,000. The charitable contribution deduction — the one that funds foundation-laundered policy influence — sent 92% of its $72 billion to the highest income bracket. PAID BY YOU
This is not a bug. The tax code is the breeding registry. It certifies the pedigree by codifying whose returns compound undisturbed and whose are clipped at the source.
The Steak Audit
A sample invoice for one theoretical "self-made" billionaire's wealth origin. Click each line to expand the receipt.
The counter-argument most often deployed here is efficiency: yes, governments funded the science, but private companies turned it into usable products. SpaceX did genuinely reduce launch costs. Pharmaceutical companies do bear real commercialization risk. This argument has merit as far as it goes — but it does not go as far as its proponents claim.
What it justifies is a partnership with shared returns. What it is used to justify is unlimited private appropriation of publicly funded upside. The NIH funded $187 billion in drug R&D; the resulting drugs are then priced at American patients 3–5x what other countries pay, because the same firms that received the public research subsidy then lobby against price negotiation. The taxpayer pays twice: once for the science, and once for the drug.
The Premium Is Real. So Is the Subsidy.
None of this argues that Wagyu beef is not better than factory-farmed beef. It is. The marbling is extraordinary. The taste is genuinely superior. The point is not to deny the premium — it is to trace the supply chain and find the subsidy.
Authentic Kobe beef requires pedigree certification (Tajima-Gyu lineage), geographic origin (Hyogo Prefecture), grade (A4 or A5), and official traceability. Japan's government provides billions annually in livestock and dairy support — the USDA estimates Japan's total livestock support at billions per fiscal year, with 97% of Japan's total agricultural subsidies supporting the sector that produces Wagyu. The product is then sold globally as the pinnacle of private luxury. The marketing erases the state from the story.
That erasure is the trick. Not the product. Not the premium. The story that the premium is self-generated — that the breed, the geography, and the quality emerged from private genius alone, without the state, without the public money, without the infrastructure no individual enterprise could have built.
The Kobe Rule holds: the story is always wrong in the same direction. The public contribution is always erased. The private brand is always foregrounded. And the erasure is not careless. It is the product.
"Tax expenditures are the most costly 'program' for the federal government — $2.2 trillion in 2025. More than Social Security. More than Medicare. More than defense."
— Peter G. Peterson Foundation, Eight Key Charts on Tax Breaks (January 2026)A useful structural observation for the arc: the subsidy doesn't just fund the product — it funds the narrative infrastructure that makes the subsidy invisible. The think tanks that produce the "government is inefficient" literature are funded by the foundations of the same people whose fortunes rest on government contracts and publicly funded research. The media outlets that amplify the self-made myth are owned by the same networks. The academic economists who model against redistribution are funded by the same endowments.
It is a closed loop. Public money in. Ideology out. Ideology protects the money. The barn funds the signs on the barn that say there is no barn. That is Episode Three's territory — narrative management as an industry in its own right. But the receipts come first.
The Receipts Are In. Next: The Factory That Makes the Signs.
Episode 03 traces the narrative management industry — the think tanks, PR firms, revolving-door economists, and media structures that exist specifically to erase the supply chain you just read.